Deadwyler
Robert Daniel Deadwyler, Roswell, GA US
Patent application number | Description | Published |
---|---|---|
20090234704 | SYSTEM AND METHOD FOR QUANTIFYING AND USING VIRTUAL TRAVEL MILEAGE - A conference scheduling device automatically collects data such as call detail records of a conferencing session from a collaborative conference unit and associates the data to each of a plurality of conference attendees. The data is converted into mileage credit for the conference attendees. Rewards may be redeemed from the accumulated mileage credit. | 09-17-2009 |
Sam Deadwyler, Winston-Salem, NC US
Patent application number | Description | Published |
---|---|---|
20140249445 | Methods and Devices for Improving Cognitive Function - The present invention provides methods and devices for improving cognitive function. In some embodiments, cognitive function is improved by detecting neuronal activity in the CA3 region of a patient's hippocampus and stimulating the CA3 region of the patient's hippocampus responsive to the neuronal activity detected. | 09-04-2014 |
Sam A. Deadwyler, Winston-Salem, NC US
Patent application number | Description | Published |
---|---|---|
20090036752 | WIRELESS SYSTEMS AND METHODS FOR THE DETECTION OF NEURAL EVENTS USING ONBOARD PROCESSING - A neural event electrode interface is configured to communicate with electrodes that capture electrical signals that are associated with at least one neuron. A neural event waveform processor is configured to extract neural events from the electrical signals. A wireless transmitter is configured to wirelessly transmit the neural events that are extracted from the electrical signals. | 02-05-2009 |
Samuel A. Deadwyler, Lewisville, NC US
Patent application number | Description | Published |
---|---|---|
20110053859 | METHODS TO REDUCE THE EFFECTS OF SLEEP DEPRIVATION - The invention provides methods of treating symptoms of sleep deprivation using a hypocretin agonist. The invention also provides methods of treating Parkinson's disease using a hypocretin agonist. | 03-03-2011 |